Skip Ribbon Commands
Skip to main content
Menu
Clin Asst Prof Victoria Ekstrom Sze Min

Clin Asst Prof Victoria Ekstrom Sze Min

​MBBS, MRCP(UK)

Consultant

Specialty: Gastroenterology & Hepatology

Sub-specialties: Gastroenterology, Hepatology, Diagnostic and Therapeutic Endoscopy, Transitional Care

Conditions Treated by this Doctor:
Abnormal Liver Function Tests, Adult Congenital Liver Disease, Colorectal Cancer Screening, Fatty Liver Diseases, Gastrooesophageal Reflux, Hepatitis B, Hepatitis C, Liver Cancer (Hepatocellular Carcinoma), Liver Cirrhosis, Liver Fibrosis, Metabolic Liver Disease, Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH), Portal Hypertension, Viral Hepatitis.

Clinical Appointments

  • Consultant Gastroenterology & Hepatology Singapore General HospitalSingapore General Hospital

Academic Appointments

  • Clinical Assistant Professor, Duke-NUS Graduate Medical School
  • Clinical Lecturer, Yong Loo Lin School of Medicine
  • Clinical Teacher, Lee Kong Chian School of Medicine

Profile

​Dr. Ekstrom Victoria Sze Min is a Consultant at the Department of Gastroenterology and Hepatology at Singapore General Hospital.

Dr. Ekstrom received her medical degree from National University of Singapore, School of Medicine in 2009. She received her specialist training in the Department of Gastroenterology at Singapore General Hospital and Changi General Hospital.

She has a special interest in Hepatology and transition care.

Education

  • ​MRCP (UK)
  • MBBS

Professional Appointments and Committee Memberships

  • ​Physician Faculty Member for Gastroenterology Residency Program
  • Internal Medicine Clinical Core Faculty Member

Awards

  • ​Young Investigator Award 2016, Asian Pacific Association for the Study of the Liver ( A novel Blood- Based 3-Gene Signature to predict development of Early Human Hepatocellular Carcinoma)
  • Outstanding Resident Award 2015
  • Best Oral Presentation, GiHep 2015

Research Interests

Publications

Publication

  • Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis. Chang PE, Goh BBG, Ekstrom V, Ong ML, Tan CK. World J Hepatol 2017; 9(22): 959-966 doi: 10.4254/wjh.v9.i22.959
  • Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism  Victoria Ekstrom; Rajneesh Kumar; Yi Zhao; Mei Ling Yee; Cynthia Sung; Dorothy Toh; Poh Yen Loh; Jessica Tan; Eng Kiong Teo; Wan Cheng Chow Gastroenterology Report 2016; doi:10.1093/gastro/gow033


Abstract

  • Prevalence of Hepatitis C virus infection and the IL28B genotype in the affected populations of Singapore. Benjy Soh Yi Min, Rajneesh Kumar , Victoria Ekstrom, Clement Lin,Sobana d/o Thangaraju, Hwee Huang Tan , Lina Hui Lin Chung, Diana Teo, Chow Wan Cheng (APASL 2017)
  • A novel blood-based 3-gene signature to predict the development of human hepatocellular carcinoma Ekstrom VSM, Wang Y, Chang PE, Goh GBB, Krishnamoorthy T, Kumar R, Handoko YA, Hui KM, Tan CK (APASL 2016, GIHep 2015)
  • Cost-Effectiveness of Pegylated Interferon and Ribavirin combination in treating Gentoype 1 Hepatitis C patients in Singapore. Victoria Sze Min Ekstrom, Mee Ling Yee, Wan Cheng Chow, Rajneesh Kumar (APASL 2015)
  • IL28B polymorphism and ITPA gene variations in Hepatitis C genotype 1 patients treated with Pegylated Interferon and Ribavirin  Ekstrom VSM, Kumar R, Zhao Y, Yee ML, Chow WC (APDW 2015)

Research Trials